(Q40645001)

22 September 2017

Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease (English)

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

author name string

X. Yataganas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

C. Papadimitriou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

G. Pangalis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

D. Loukopoulos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

P. Fessas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

N. Papacharalampous

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A300650

2 March 2023

language of work or name

English

0 references

publication date

1 May 1977

1 reference

full work available at URL

22 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

1 reference

22 September 2017

39

1 reference

22 September 2017

5

1 reference

22 September 2017

2183-2189

1 reference

Lymphadenopathy simulating the malignant lymphomas

22 September 2017

2

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Angio-immunoblastic lymphadenopathy with dysproteinaemia

2 March 2023

3

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course

2 March 2023

4

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Genetically determined immune deficiency as the predisposing cause of "autoimmunity" and lymphoid neoplasia

2 March 2023

5

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Relations between Immunity and Malignancy

2 March 2023

6

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Postvaccinial lymphadenitis. Hyperplasia of lymphoid tissue that simulates malignant lymphomas

2 March 2023

7

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

8

32

270

Hays

1972

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Auto-immunity in man and homologous disease in mice in relation to the malignant lymphomas

2 March 2023

9

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease

2 March 2023

11

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

12

31

1755

Lukes

1971

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Pathogenesis of Hodgkin's disease

2 March 2023

13

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder

2 March 2023

14

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

"Reed-Sternberg cells" in infectious mononucleosis?

2 March 2023

17

1 reference

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

https://api.crossref.org/works/10.1002/1097-0142(197705)39:5%3C2183::AID-CNCR2820390535%3E3.0.CO;2-7

2 March 2023

Identifiers

10.1002/1097-0142(197705)39:5<2183::AID-CNCR2820390535>3.0.CO;2-7

1 reference

22 September 2017

1 reference